Cardiovascular failure in mouse embryos deficient in VEGF receptor-3

被引:639
作者
Dumont, DJ
Jussila, L
Taipale, J
Lymboussaki, A
Mustonen, T
Pajusola, K
Breitman, M
Alitalo, K
机构
[1] Univ Helsinki, Haartman Inst, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[3] Univ Toronto, Amgen Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada
[4] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada
关键词
D O I
10.1126/science.282.5390.946
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Vascular endothelial growth factor (VEGF) is a key regulator of blood vessel development in embryos and angiogenesis in adult tissues. Unlike VEGF, the related VEGF-C stimulates the growth of Lymphatic vessels through its specific Lymphatic endothelial receptor VEGFR-3. Here it is shown that targeted inactivation of the gene encoding VEGFR-3 resulted in defective blood vessel development in early mouse embryos. Vasculogenesis and angiogenesis occurred, but Large vessels became abnormally organized with defective lumens, Leading to fluid accumulation in the pericardial cavity and cardiovascular failure at embryonic day 9.5. Thus, VEGFR-3 has an essential role in the development of the embryonic cardiovascular system before the emergence of the Lymphatic vessels.
引用
收藏
页码:946 / 949
页数:4
相关论文
共 30 条
[1]   Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4) [J].
Achen, MG ;
Jeltsch, M ;
Kukk, E ;
Mäkinen, T ;
Vitali, A ;
Wilks, AF ;
Alitalo, K ;
Stacker, SA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) :548-553
[2]   Role of tissue factor in embryonic blood vessel development [J].
Carmeliet, P ;
Mackman, N ;
Moons, L ;
Luther, T ;
Gressens, P ;
VanVlaenderen, I ;
Demunck, H ;
Kasper, M ;
Breier, G ;
Evrard, P ;
Muller, M ;
Risau, W ;
Edgington, T ;
Collen, D .
NATURE, 1996, 383 (6595) :73-75
[3]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[4]  
Eichmann A, 1998, DEVELOPMENT, V125, P743
[5]   The biology of vascular endothelial growth factor [J].
Ferrara, N ;
DavisSmyth, T .
ENDOCRINE REVIEWS, 1997, 18 (01) :4-25
[6]   ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM [J].
FONG, GH ;
ROSSANT, J ;
GERTSENSTEIN, M ;
BREITMAN, ML .
NATURE, 1995, 376 (6535) :66-70
[7]   Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice [J].
Hiratsuka, S ;
Minowa, O ;
Kuno, J ;
Noda, T ;
Shibuya, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (16) :9349-9354
[8]   Hyperplasia of lymphatic vessels in VEGF-C transgenic mice [J].
Jeltsch, M ;
Kaipainen, A ;
Joukov, V ;
Meng, XJ ;
Lakso, M ;
Rauvala, H ;
Swartz, M ;
Fukumura, D ;
Jain, RK ;
Alitalo, K .
SCIENCE, 1997, 276 (5317) :1423-1425
[9]  
Joukov V, 1996, EMBO J, V15, P290
[10]  
JUSSILA L, UNPUB